Tech Partnerships

Business

Fortive's Stock Slump Sparks Valuation Debate: Is the Industrial Tech Firm a Bargain?

Fortive Corporation's shares have retreated over 5% in the past month, prompting investors to re-examine the industrial technology conglomerate's fundamentals. With a renewed focus on its recurring revenue streams and a fair value estimate suggesting upside, analysts are divided on whether the pullback presents a buying opportunity or reflects deeper sector headwinds.

Jan 30, 2026

Business

Aurelius Technologies Berhad: Is the Current Share Price Justified?

A deep dive into the intrinsic value of Aurelius Technologies Berhad (KLSE:ATECH) using a Discounted Cash Flow model suggests a potential disconnect between its market price and fundamental valuation, raising questions for investors.

Jan 30, 2026

Business

Pantech Group Holdings: Is the Malaysian Piping Giant Trading at a Fair Price?

A deep dive into Pantech Group Holdings Berhad's valuation using a Discounted Cash Flow model suggests the stock may be trading close to its intrinsic value, offering investors a potential entry point in the industrial supplies sector.

Jan 30, 2026

Business

Against the Odds: How Ethos Defied the Insurtech Curse to Reach Nasdaq

As a profitable outlier in a battered sector, Ethos Technologies' successful IPO marks a pivotal test for investor appetite in 2026's tech listings, even as its debut valuation reflects a more sober market reality.

Jan 30, 2026

Business

Beyond the Tech Bro Dream: How Electricians, Librarians, and Roofers Are Redefining Early Retirement

The FIRE movement is no longer the exclusive domain of high-flying tech salaries. A growing community of middle and working-class Americans is proving that strategic frugality and disciplined investing can pave the way to financial independence decades ahead of schedule.

Feb 2, 2026

Business

Vidhance's Cash Runway: A Closer Look at the Video Tech Firm's Financial Position

While Vidhance (FRA:8W50) continues to operate at a loss, its current cash reserves and manageable burn rate suggest the company has time to execute its growth strategy. However, a recent dip in revenue adds a note of caution for investors.

Feb 2, 2026

Business

InflaRx's Cash Runway Narrows: Can the Biotech Steer Through Financial Headwinds?

With a cash reserve that could last just over a year at its current burn rate, InflaRx faces a critical period to prove its clinical pipeline's value. While management has reined in spending, the company's financial strategy is now under the microscope.

Feb 2, 2026

Business

Eli Lilly Doubles Down: $3.5 Billion Bet on Next-Gen Obesity Drugs and Gene Therapy Partnerships

Pharmaceutical giant Eli Lilly announces a major $3.5 billion manufacturing expansion for its weight-loss drugs and enters two strategic research collaborations in gene editing and immunology, signaling aggressive growth plans amid a recent stock valuation dip.

Feb 2, 2026

Business

Merck Pivots Oncology Strategy: Partnerships Over Mega-Deals as Market Questions Valuation

Merck & Co. shifts its cancer drug development playbook, opting for targeted collaborations with Guardant Health and Eikon Therapeutics after walking away from a major acquisition. Analysts debate whether the stock's current price fully reflects its long-term pipeline potential.

Jan 30, 2026

Business

Brazilian Fintech Giant Nubank Clears Key U.S. Hurdle, Paving Way for National Bank and Potential Crypto Services

The U.S. Office of the Comptroller of the Currency has granted Nubank conditional approval to establish a national bank, a significant step that could see the digital banking leader offer federally regulated crypto custody alongside traditional banking products in the United States.

Jan 30, 2026

Business

Wall Street Split on CCC Intelligent Solutions: A Clash of Visions for the Claims Tech Leader

Divergent analyst reports from Truist and Goldman Sachs on CCC Intelligent Solutions have cast a spotlight on the data firm's path to profitability, revealing deep-seated debates about its role in the auto insurance ecosystem and its ability to convert steady growth into sustained margins.

Jan 30, 2026

Business

Lilly Bets Big on Repertoire's Immune Decoding Tech in Up to $1.9B Autoimmune Pact

Eli Lilly commits $85 million upfront and over $1.8 billion in potential milestones to partner with Repertoire Immune Medicines, aiming to develop a new class of 'tolerizing' therapies that reset the immune system without broad suppression.

Jan 30, 2026

Business

Uber's Autonomous Ambitions Face Reality Check as New Jersey Ruling Reclassifies Drivers

Uber Technologies is aggressively expanding its autonomous vehicle ecosystem through new partnerships and its AV Labs division, even as a landmark New Jersey court decision threatens to upend its core gig-economy labor model, setting the stage for a pivotal clash between its future vision and present-day regulatory challenges.

Jan 30, 2026

Business

Bank of America Lifts Target on Xencor Amid Broader Biotech Sector Optimism

Bank of America has raised its price target for clinical-stage biopharma firm Xencor (XNCR), highlighting a cautiously improving landscape for the sector driven by data catalysts, M&A, and capital access.

Jan 30, 2026

Business

OpenAI's $100B+ Funding Round Draws Tech Titans Amazon, Microsoft, Nvidia

As OpenAI accelerates toward a potential year-end IPO, Amazon, Microsoft, and Nvidia are in advanced talks to lead a funding round that could exceed $100 billion, reshaping the AI industry's financial and competitive landscape.

Jan 30, 2026

Business

Bread Financial Caps 2025 with Strong Growth, Eyes Further Diversification and Tech Investment

Bread Financial (NYSE: BFH) delivered robust fourth-quarter and full-year 2025 results, meeting expectations through strategic partner expansions, improved credit health, and strengthened capital positioning. Management outlines a 2026 roadmap focused on sustainable growth, deposit mix optimization, and leveraging AI across operations.

Jan 30, 2026

Business

Qualcomm's Strategic Pivot: From Mobile Dominance to AI at the Edge

Qualcomm is aggressively diversifying its business beyond smartphones, forging new partnerships in drone security and legal tech to establish its Snapdragon platform as a cornerstone for on-device AI and edge computing.

Jan 30, 2026

Business

Twist Bioscience Posts 12th Straight Quarter of Growth, Fueled by AI-Driven Biotech Demand

Synthetic biology leader Twist Bioscience reported strong Q1 FY2026 results, with revenue climbing 17% year-over-year to $103.7 million. Management highlighted accelerating demand from AI-powered drug discovery and reiterated its path to adjusted EBITDA breakeven by Q4 FY2026.

Feb 2, 2026

Business

Amgen's Q4 Preview: Wall Street's Mixed Signals on the Biotech Giant

As Amgen prepares to report earnings, analysts are divided on the stock's trajectory. While strategic acquisitions and a solid track record fuel optimism, looming competitive pressures and a key pipeline wait temper expectations.

Feb 2, 2026

Business

Beyond the Wrist: Smart Patches Emerge as Next Frontier in Wearable Health Tech

As the wearables market surges, Biolinq CEO Richard Yang positions smart patches as the next evolution, capable of tracking deep biochemical data where watches track surface metrics, with his company's FDA-cleared glucose sensor leading the charge.

Feb 2, 2026